Advisory Board
Industry veterans, thought leaders, and strategic advisors who provide governance, strategic direction, and expert counsel — bringing diverse perspectives from academia, industry, and regulatory agencies.
Professor Raghunadharao Digumarti, MD, DM, FRCP, FACP
Visionary Oncologist, Clinical Research Pioneer & Institution Builder
A preeminent medical oncologist and transformative leader with over four decades dedicated to advancing cancer care, clinical research, and medical education in India. Professor Digumarti is renowned for founding and directing comprehensive cancer hospitals, establishing pioneering clinical trial units, and shaping national oncology policy.
Dr. Robert L. De Jager, M.D., F.A.C.P.
Pioneering Oncology Drug Developer & Translational Research Leader
A visionary physician-executive with over 40 years of distinguished experience in anticancer drug development. Dr. De Jager has been instrumental in the clinical strategy and execution for numerous first-in-class therapies, from early translational research through global regulatory approval.
Dr. William E. Gannon, Jr., M.D., M.B.A.
Chief Scientific Officer & Medical Director, Capital City Technical Consulting
Dr. Gannon brings deep experience in clinical trial management, regulatory strategy, and operational leadership across CROs, biotech, device, and pharmaceutical firms. He has designed and executed Phase I–IV programs globally with a focus in oncology and broad therapeutic expertise, providing strategic guidance on program development and risk mitigation.
Our Advisory Board is Expanding
We're actively recruiting additional distinguished members to bring even broader expertise to our clients.
Interested in joining our mission to accelerate life-saving therapies? Contact us to explore partnership opportunities.
